ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos251.25 M247.78 M259.79 M265.09 M275.68 M1.05 BInvestigación y desarrollo57.73 M59.06 M61.9 M63.41 M66.83 M251.21 MBeneficio operativo261.69 M316.53 M373.05 M354.85 M315.61 M1.36 BTotal de ingresos no operativos——————Gastos por intereses, netos de intereses capitalizados7.5 M7.67 M11.32 M10.65 M9.21 M38.85 MIngresos no operativos, una vez deducidos los gastos por intereses——————Ingresos/gastos extraordinarios——————Beneficio antes de impuestos256.39 M310.08 M362.35 M344.77 M306.98 M1.32 BParticipación en los beneficios——————Impuestos40.24 M67.41 M68.36 M70.16 M58.79 M264.73 MParticipación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BOperaciones suspendidas——————Beneficio neto216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas216.15 M242.68 M293.99 M274.61 M248.19 M1.06 BBeneficio básico por acción2.642.983.663.433.113.17Beneficio por acción diluido2.622.963.633.43.0913.08Número medio de acciones ordinarias82.47 M81.32 M80.41 M80.1 M80.43 M322.25 MAcciones diluidas83.25 M81.92 M80.99 M80.67 M81.03 M324.62 MEBITDA291.82 M347.71 M405.88 M388.24 M349.43 M1.49 BEBIT258.11 M313.64 M370.11 M351.61 M310.7 M1.35 BCosto de los ingresos385.42 M375.05 M416.19 M423.5 M434.92 M1.65 BOtros costes de producción——————Amortización y depreciación (flujo de caja)33.71 M34.06 M35.77 M36.63 M38.72 M145.18 M
IDEXX Laboratories Inc
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.